Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results

ACCESSWIRE11-14

VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483861449?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/E3g6btrTM84_NQnTxpGTzg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9e942b27095165768c1101e200782175","is_english":true,"pubTime":"2024-11-14 06:56","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483861449","market":"us","top_or_hot":-1,"title":"Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results","media":"ACCESSWIRE","content":"<div>\n<p>VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (\"Inspire\" or the \"Company\"), an owner and provider of pet health care services throughout the U.S....</p>\n\n<a href=\"https://finance.yahoo.com/news/inspire-veterinary-partners-reports-third-225600529.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInspire Veterinary Partners Reports Third Quarter 2024 Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 06:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/inspire-veterinary-partners-reports-third-225600529.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (\"Inspire\" or the \"Company\"), an owner and provider of pet health care services throughout the U.S....</p>\n\n<a href=\"https://finance.yahoo.com/news/inspire-veterinary-partners-reports-third-225600529.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IVP","symbol_name":"Inspire Veterinary Partners, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/inspire-veterinary-partners-reports-third-225600529.html","article_id":"2483861449","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/E3g6btrTM84_NQnTxpGTzg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9e942b27095165768c1101e200782175"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483861449","pubTimestamp":1731538560,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc.  , an owner and provider of pet health care services throughout the U.S., today reported its financial results for the third quarter and nine months ended September 30, 2024.Select Third Quarter 2024 Highlights Compared to Prior Year Period. Total revenue of approximately $4.0 million, a decrease of 1.7%. Services revenue of $2.9 million, an increase of 1%. Total revenue of approximately $13.3 million, an increase of 3%. Services revenue of approximately $9.7 million, an increase of 6%. General and administrative expenses decreased 16% to $3.0 million for the third quarter of 2024 compared to $3.5 million in the prior year period. The decrease was primarily due to the Company's decrease in payroll cost from a reduced headcount, cost associated with the initial public offering in August 2023 and termination of the consulting arrangements with Blue Herron and Star Circle.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IVP":"Inspire Veterinary Partners, Inc.","BK4185":"保健护理机构"},"translate_title":"Inspire Veterinary Partners报告2024年第三季度财务业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IVP":1},"content_text":"VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (\"Inspire\" or the \"Company\"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the third quarter and nine months ended September 30, 2024.\nSelect Third Quarter 2024 Highlights Compared to Prior Year Period\n\nTotal revenue of approximately $4.0 million, a decrease of 1.7%\nServices revenue of $2.9 million, an increase of 1%\nProduct revenue of $1.1 million, a decrease of 9%\nG&A decreased 16%\nNet loss decreased 56%\nTotal revenue of approximately $13.3 million, an increase of 3%\nServices revenue of approximately $9.7 million, an increase of 6%\nProduct revenue of $3.5 million, a decrease of 4%\nG&A increased 11%\nNet loss decreased 3%\n\nSelect Nine Month 2024 Highlights Compared to Prior Year Period\n\nTotal revenue of approximately $13.3 million, an increase of 3%\nServices revenue of approximately $9.7 million, an increase of 6%\nProduct revenue of $3.5 million, a decrease of 4%\nG&A increased 11%\nNet loss decreased 3%\n\n\"Our third quarter results demonstrate the ongoing work of our dedicated teams on key initiatives to strengthen our fundamentals and accelerate the path to improved profitability,\" said Kimball Carr, President & Chief Executive Officer of Inspire. \"While our third quarter total revenue was slightly lower on a quarterly comparative basis, we continued to streamline our operations to lower our cost structure, leading to a 16% decrease in G&A and a reduction in net loss. Looking ahead, I see tremendous opportunities for us to significantly improve our operating and financial performance and better leverage IVP's platform by continuing to add attractive single and multi-unit animal hospitals, and other synergistic products and services. We remain confident in our direction and belief that the changes and investments we are making across our business will create a more compelling, enduring value proposition for all stakeholders.\"\nThird Quarter 2024 Highlights Compared to Prior Year Period\nTotal revenue was approximately $4.0 million for the third quarter of 2024, a decrease of 1.7% compared to total revenue of $4.1 million in the prior year period. Service revenue for the third quarter of 2024 increased 1% to $2.9 million compared to the prior year period, primarily driven by the acquisition of Valley Veterinary animal hospital in the fourth quarter of 2023. Product revenue of $1.1 million decreased 9% compared to the prior year period driven primarily bycustomers purchasing less products per visit.\nGeneral and administrative expenses decreased 16% to $3.0 million for the third quarter of 2024 compared to $3.5 million in the prior year period. The decrease was primarily due to the Company's decrease in payroll cost from a reduced headcount, cost associated with the initial public offering in August 2023 and termination of the consulting arrangements with Blue Herron and Star Circle.\nNet loss decreased 56% to $3.5 million for the third quarter of 2024 compared to a net loss of $7.9 million for the prior year period which included the beneficial conversion feature on the convertible debenture and series A preferred stock of approximately $4.1 million recognized upon the completion of the IPO.\nBalance Sheet\nAs of September 30, 2024, the Company had cash and cash equivalents of approximately $0.68 million. Subsequent to the end of the third quarter of 2024, the Company closed its previously announced registered direct offering on October 23 for the purchase and sale of an aggregate of 10 million shares of its Class A common stock at a purchase price of $0.25 per share. The aggregate gross proceeds to the Company from the offering were $2.5 million, prior to deducting placement agent's fees and other offering expenses payable by Inspire.\nInspire Veterinary Partners, Inc. and SubsidiariesUnaudited Condensed Consolidated Balance Sheets\n\n\n\n\n\n\n\n\nSeptember 30,\n\n\nDecember 31,\n\n\n\n\n\n\n\n2024\n\n\n2023\n\n\n\n\n\nAssets\n\n\n\n\n\n\n\n\n\n\n\n      Current assets:\n     \n\n\n\n\n\n\n\n\n\n\n      Cash and cash equivalents\n     \n\n$\n681,199\n\n\n$\n178,961\n\n\n\n\n\n      Accounts receivable, net\n     \n\n\n115,551\n\n\n\n28,573\n\n\n\n\n\n      Due from former owners\n     \n\n\n-\n\n\n\n32,519\n\n\n\n\n\n      Inventory\n     \n\n\n563,595\n\n\n\n571,512\n\n\n\n\n\n      Refundable income tax\n     \n\n\n-\n\n\n\n151,796\n\n\n\n\n\n      Prepaid expenses and other current assets\n     \n\n\n3,090,371\n\n\n\n388,759\n\n\n\n\n\n      Total current assets\n     \n\n\n4,450,716\n\n\n\n1,352,120\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Restricted cash - non-current\n     \n\n\n200,000\n\n\n\n200,000\n\n\n\n\n\n      Property and equipment, net\n     \n\n\n6,486,444\n\n\n\n7,949,144\n\n\n\n\n\n      Right-of-use assets\n     \n\n\n1,347,026\n\n\n\n1,616,198\n\n\n\n\n\n      Other intangibles, net\n     \n\n\n1,864,355\n\n\n\n2,513,028\n\n\n\n\n\nGoodwill\n\n\n\n8,022,082\n\n\n\n8,147,590\n\n\n\n\n\n      Other assets\n     \n\n\n25,115\n\n\n\n12,895\n\n\n\n\n\n      Total assets\n     \n\n$\n22,395,738\n\n\n$\n21,790,975\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLiabilities and Stockholder's Equity (Deficit)\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Current liabilities:\n     \n\n\n\n\n\n\n\n\n\n\n\n\n      Accounts payable\n     \n\n$\n2,073,582\n\n\n$\n3,206,594\n\n\n\n\n\n      Accrued expenses\n     \n\n\n305,118\n\n\n\n858,334\n\n\n\n\n\n      Cumulative Series A preferred stock dividends payable\n     \n\n\n-\n\n\n\n92,322\n\n\n\n\n\n      Operating lease liabilities\n     \n\n\n164,107\n\n\n\n141,691\n\n\n\n\n\n      Loans payable, net of discount\n     \n\n\n2,233,004\n\n\n\n1,713,831\n\n\n\n\n\n      Convertible notes payable\n     \n\n\n850,000\n\n\n\n-\n\n\n\n\n\n      Convertible debentures, net of issuance costs\n     \n\n\n-\n\n\n\n100,000\n\n\n\n\n\n      Notes payable, net of discount\n     \n\n\n1,401,449\n\n\n\n1,469,043\n\n\n\n\n\n      Total current liabilities\n     \n\n\n7,027,260\n\n\n\n7,581,815\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Operating lease liabilities, non-current\n     \n\n\n1,417,372\n\n\n\n1,514,044\n\n\n\n\n\n      Notes payable - noncurrent\n     \n\n\n10,921,103\n\n\n\n13,483,375\n\n\n\n\n\n      Total liabilities\n     \n\n\n19,365,735\n\n\n\n22,579,234\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Commitments and Contingencies (Note 15)\n     \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Stockholder's Equity (Deficit)\n     \n\n\n\n\n\n\n\n\n\n\n\n\n      Common stock - Class A, $0.0001 par value, 100 million shares authorized, 13,363,688 and 70,421 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.\n     \n\n\n1,336\n\n\n\n7\n\n\n\n\n\n      Common stock - Class B, $0.0001 par value, 20 million shares authorized, 3,891,500 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.\n     \n\n\n389\n\n\n\n389\n\n\n\n\n\n      Convertible series A preferred stock, $0.0001 par value, 1 million shares authorized, 0 and 403,640 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.\n     \n\n\n-\n\n\n\n40\n\n\n\n\n\n      Additional paid in capital\n     \n\n\n34,761,924\n\n\n\n20,426,562\n\n\n\n\n\n      Accumulated deficit\n     \n\n\n(31,733,646\n)\n\n\n(21,215,257\n)\n\n\n\n\n      Total stockholder's equity (deficit)\n     \n\n\n3,030,003\n\n\n\n(788,259\n)\n\n\n\n\n      Total liabilities and stockholder's equity (deficit)\n     \n\n$\n22,395,738\n\n\n$\n21,790,975\n\n\n\n\n\nInspire Veterinary Partners, Inc. and SubsidiariesUnaudited Condensed Consolidated Statements of Operations\n\n\n\n\n\n\n\n\nFor the Three Months EndedSeptember 30,\n\n\nFor the Nine Months EndedSeptember 30,\n\n\n\n\n\n\n\n2024\n\n\n2023\n\n\n2024\n\n\n2023\n\n\n\n\n\n      Service revenue\n     \n\n$\n2,969,748\n\n\n$\n2,935,922\n\n\n$\n9,735,585\n\n\n$\n9,209,501\n\n\n\n\n\n      Product revenue\n     \n\n\n1,079,277\n\n\n\n1,183,726\n\n\n\n3,535,388\n\n\n\n3,682,088\n\n\n\n\n\n      Total revenue\n     \n\n\n4,049,025\n\n\n\n4,119,648\n\n\n\n13,270,973\n\n\n\n12,891,589\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Operating expenses\n     \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Cost of service revenue (exclusive of depreciation and amortization, shown separately below)\n     \n\n\n2,568,085\n\n\n\n2,206,216\n\n\n\n7,705,972\n\n\n\n6,847,963\n\n\n\n\n\n      Cost of product revenue (exclusive of depreciation and amortization, shown separately below)\n     \n\n\n854,921\n\n\n\n853,622\n\n\n\n2,807,025\n\n\n\n2,631,752\n\n\n\n\n\n      General and administrative expenses\n     \n\n\n2,988,122\n\n\n\n3,561,790\n\n\n\n8,080,199\n\n\n\n7,249,250\n\n\n\n\n\n      Debt extinguishment loss\n     \n\n\n-\n\n\n\n16,105\n\n\n\n1,587,862\n\n\n\n16,105\n\n\n\n\n\n      Depreciation and amortization\n     \n\n\n340,167\n\n\n\n313,316\n\n\n\n1,048,290\n\n\n\n915,824\n\n\n\n\n\n      Gain on sale of business\n     \n\n\n(467,049\n)\n\n\n-\n\n\n\n(467,049\n)\n\n\n-\n\n\n\n\n\n      Total operating expenses\n     \n\n\n6,284,246\n\n\n\n6,951,049\n\n\n\n20,762,299\n\n\n\n17,660,894\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Loss from operations\n     \n\n\n(2,235,221\n)\n\n\n(2,831,401\n)\n\n\n(7,491,326\n)\n\n\n(4,769,305\n)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Other income (expenses):\n     \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Interest income\n     \n\n\n44\n\n\n\n12\n\n\n\n46\n\n\n\n18\n\n\n\n\n\n      Interest expense\n     \n\n\n(1,254,149\n)\n\n\n(914,604\n)\n\n\n(2,801,491\n)\n\n\n(1,745,415\n)\n\n\n\n\n      Beneficial conversion feature\n     \n\n\n-\n\n\n\n(4,137,261\n)\n\n\n-\n\n\n\n(4,137,261\n)\n\n\n\n\n      Other expenses\n     \n\n\n-\n\n\n\n(748\n)\n\n\n(4,768\n)\n\n\n1,218\n\n\n\n\n\n      Total other expenses\n     \n\n\n(1,254,105\n)\n\n\n(5,052,601\n)\n\n\n(2,806,213\n)\n\n\n(5,881,440\n)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Loss before income taxes\n     \n\n\n(3,489,326\n)\n\n\n(7,884,002\n)\n\n\n(10,297,539\n)\n\n\n(10,650,745\n)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Benefit for income taxes\n     \n\n\n-\n\n\n\n-\n\n\n\n-\n\n\n\n-\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Net loss\n     \n\n\n(3,489,326\n)\n\n\n(7,884,002\n)\n\n\n(10,297,539\n)\n\n\n(10,650,745\n)\n\n\n\n\n      Dividend on convertible series A preferred stock\n     \n\n\n-\n\n\n\n(133,828\n)\n\n\n(220,850\n)\n\n\n(133,828\n)\n\n\n\n\n      Net loss attributable to class A and B common stockholders\n     \n\n$\n(3,489,326\n)\n\n$\n(8,017,830\n)\n\n$\n(10,518,389\n)\n\n$\n(10,784,573\n)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Net loss per Class A and B common shares:\n     \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Basic and diluted\n     \n\n$\n(0.38\n)\n\n$\n(1.86\n)\n\n$\n(1.75\n)\n\n$\n(2.50\n)\n\n\n\n\n      Weighted average shares outstanding per Class A and B common shares:\n     \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n      Basic and diluted\n     \n\n\n9,070,371\n\n\n\n4,321,507\n\n\n\n6,019,913\n\n\n\n4,313,683\n\n\n\n\n\nInspire Veterinary Partners, Inc. and SubsidiariesUnaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)\n\n\n\n\n\nConvertible Series A\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPreferred Stock\n\nClass A Common Stock\n\nClass B Common Stock\n\nAdditional\n\nAccumulated\n\n\nStockholders'Equity\n\n\n\n\n\n\nNo. ofShares\n\nAmount\n\nNo. ofShares\n\nAmount\n\nNo. ofShares\n\nAmount\n\nPaid-in Capital\n\n\n\nDeficit\n\n\n(As Restated)\n\n\n\n\n\n(Deficit)\n\n\n(As Restated)\n\n\n\n\n\n\nBalance as of December 31, 2022\n\n\n-\n\n$\n-\n\n\n9,705\n\n$\n1\n\n\n4,300,000\n\n$\n430\n\n$\n1,107,536\n\n$\n(6,243,448\n)\n\n$\n(5,135,481\n)\n\n\n\n\n      Issuance of warrants to CEO\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n2,701\n\n\n-\n\n\n\n2,701\n\n\n\n\n\n      Net loss\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(1,538,949\n)\n\n\n(1,538,949\n)\n\n\n\n\nBalance as of March 31, 2023\n\n\n-\n\n$\n-\n\n\n9,705\n\n$\n1\n\n\n4,300,000\n\n$\n430\n\n$\n1,110,237\n\n$\n(7,782,397\n)\n\n$\n(6,671,729\n)\n\n\n\n\n      Issuance of convertible series A preferred stock in exchange for bridge note (contingent upon a qualified offering as of or before September 1, 2023 (See note 8))\n     \n\n442,458\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n\n-\n\n\n\n\n\n      Net loss\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(1,227,794\n)\n\n\n(1,227,794\n)\n\n\n\n\nBalance as of June 30, 2023\n\n\n442,458\n\n$\n-\n\n\n9,705\n\n$\n1\n\n\n4,300,000\n\n$\n430\n\n$\n1,110,237\n\n$\n(9,010,191\n)\n\n$\n(7,899,523\n)\n\n\n\n\n      Issuance of class A common stock in connection with initial public offering, net of issuance costs\n     \n\n-\n\n\n-\n\n\n16,000\n\n\n2\n\n\n-\n\n\n-\n\n\n5,439,569\n\n\n-\n\n\n\n5,439,571\n\n\n\n\n\n      Recognition of convertible series A preferred stock issuance upon initial public offering\n     \n\n-\n\n\n44\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n4,440,644\n\n\n-\n\n\n\n4,440,688\n\n\n\n\n\n      Conversion of convertible debentures into class A common stock\n     \n\n-\n\n\n-\n\n\n14,959\n\n\n1\n\n\n-\n\n\n-\n\n\n4,414,316\n\n\n-\n\n\n\n4,414,317\n\n\n\n\n\n      Conversion of class B common stock into class A common stock\n     \n\n-\n\n\n-\n\n\n4,085\n\n\n-\n\n\n(408,500\n)\n\n(41\n)\n\n41\n\n\n-\n\n\n\n-\n\n\n\n\n\n      Convertible series A preferred stock cumulative dividends\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(133,828\n)\n\n-\n\n\n\n(133,828\n)\n\n\n\n\n      Issuance of common stock for services\n     \n\n-\n\n\n-\n\n\n1,302\n\n\n-\n\n\n-\n\n\n-\n\n\n197,892\n\n\n-\n\n\n\n197,892\n\n\n\n\n\n      Beneficial conversion feature on convertible debentures\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n1,569,395\n\n\n-\n\n\n\n1,569,395\n\n\n\n\n\n      Beneficial conversion feature on convertible series A preferred stock\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n2,567,866\n\n\n-\n\n\n\n2,567,866\n\n\n\n\n\n      Net loss\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(7,884,002\n)\n\n\n(7,884,002\n)\n\n\n\n\nBalance as of September 30, 2023\n\n\n442,458\n\n$\n44\n\n\n46,051\n\n$\n5\n\n\n3,891,500\n\n$\n389\n\n$\n19,606,132\n\n$\n(16,894,193\n)\n\n$\n2,712,376\n\n\n\n\n\n\n\n\n\n\n\n\nConvertible Series APreferred Stock\n\nClass A Common Stock\n\nClass B Common Stock\n\n\n\n\n\n\n\n\n\n\n\n\n\nNo. ofShares\n\nAmount\n\nNo. ofShares\n\nAmount\n\nNo. ofShares\n\nAmount\n\nAdditionalPaid-in Capital\n\n\n\nAccumulated\n\n\nDeficit\n\n\n\nStockholder'Equity (Deficit)\n\n\n\n\n\nBalance as of December 31, 2023\n\n\n403,640\n\n$\n40\n\n\n70,421\n\n$\n7\n\n\n3,891,500\n\n$\n389\n\n$\n20,426,562\n\n$\n(21,215,257\n)\n\n$\n(788,259\n)\n\n\n\n\n      Issuance of class A common stock and pre-funded warrants, net of issuance costs\n     \n\n-\n\n\n-\n\n\n28,599\n\n\n3\n\n\n-\n\n\n-\n\n\n3,375,455\n\n\n-\n\n\n\n3,375,458\n\n\n\n\n\n      Exercise of pre-funded warrants\n     \n\n-\n\n\n-\n\n\n441,989\n\n\n44\n\n\n-\n\n\n-\n\n\n(44\n)\n\n-\n\n\n\n-\n\n\n\n\n\n      Issuance of Class A common stock and pre-funded warrants in connection with commitment shares\n     \n\n-\n\n\n-\n\n\n12,143\n\n\n1\n\n\n-\n\n\n-\n\n\n599,999\n\n\n-\n\n\n\n600,000\n\n\n\n\n\n      Issuance of convertible series A preferred stock\n     \n\n20,000\n\n\n2\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n199,998\n\n\n-\n\n\n\n200,000\n\n\n\n\n\n      Issuance of class A common stock for services\n     \n\n-\n\n\n-\n\n\n39,051\n\n\n4\n\n\n-\n\n\n-\n\n\n286,692\n\n\n-\n\n\n\n286,696\n\n\n\n\n\n      Issuance of class A common stock in connection with general release agreement\n     \n\n-\n\n\n-\n\n\n2,460\n\n\n-\n\n\n-\n\n\n-\n\n\n20,000\n\n\n-\n\n\n\n20,000\n\n\n\n\n\n      Conversion of convertible series A preferred stock into class A common stock\n     \n\n(363,725\n)\n\n(36\n)\n\n147,900\n\n\n15\n\n\n-\n\n\n-\n\n\n21\n\n\n-\n\n\n\n-\n\n\n\n\n\n      Convertible series A preferred stock cumulative dividends\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(2,250\n)\n\n-\n\n\n\n(2,250\n)\n\n\n\n\n      Convertible series A preferred stock dividend\n     \n\n21,227\n\n\n2\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n212,268\n\n\n(212,270\n)\n\n\n-\n\n\n\n\n\n      Net loss\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(3,421,792\n)\n\n\n(3,421,792\n)\n\n\n\n\nBalance as of March 31, 2024\n\n\n81,142\n\n$\n8\n\n\n742,563\n\n$\n74\n\n\n3,891,500\n\n$\n389\n\n$\n25,118,701\n\n$\n(24,849,319\n)\n\n$\n269,853\n\n\n\n\n\n      Exercise of pre-funded warrants\n     \n\n-\n\n\n-\n\n\n102,500\n\n\n10\n\n\n-\n\n\n-\n\n\n(10\n)\n\n-\n\n\n\n-\n\n\n\n\n\n      Conversion of convertible series A preferred stock into class A common stock\n     \n\n(54,771\n)\n\n(5\n)\n\n198,992\n\n\n20\n\n\n-\n\n\n-\n\n\n(15\n)\n\n-\n\n\n\n-\n\n\n\n\n\n      Convertible series A preferred stock dividend\n     \n\n858\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n10,830\n\n\n(8,580\n)\n\n\n2,250\n\n\n\n\n\n      Net loss\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(3,386,421\n)\n\n\n(3,386,421\n)\n\n\n\n\nBalance as of June 30, 2024\n\n\n27,229\n\n$\n3\n\n\n1,044,055\n\n$\n104\n\n\n3,891,500\n\n$\n389\n\n$\n25,129,506\n\n$\n(28,244,320\n)\n\n$\n(3,114,318\n)\n\n\n\n\n      Issuance of class A common stock and warrants, net of issuance costs\n     \n\n-\n\n\n-\n\n\n146,475\n\n\n15\n\n\n-\n\n\n-\n\n\n5,459,985\n\n\n-\n\n\n\n5,460,000\n\n\n\n\n\n      Exercise of pre-funded warrants\n     \n\n-\n\n\n-\n\n\n5,853,846\n\n\n585\n\n\n-\n\n\n-\n\n\n(585\n)\n\n-\n\n\n\n-\n\n\n\n\n\n      Exercise of class A common stock warrants\n     \n\n-\n\n\n-\n\n\n3,500,000\n\n\n350\n\n\n-\n\n\n-\n\n\n3,499,650\n\n\n-\n\n\n\n3,500,000\n\n\n\n\n\n      Conversion of convertible series A preferred stock into class A common stock\n     \n\n(27,229\n)\n$\n(3\n)\n\n272,290\n\n$\n27\n\n\n-\n\n\n-\n\n\n(24\n)\n\n-\n\n\n\n-\n\n\n\n\n\n      Conversion of convertible notes payable\n     \n\n-\n\n\n-\n\n\n2,547,022\n\n\n255\n\n\n-\n\n\n-\n\n\n649,745\n\n\n-\n\n\n\n650,000\n\n\n\n\n\n      Stock-based compensation\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n23,647\n\n\n-\n\n\n\n23,647\n\n\n\n\n\n      Net loss\n     \n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n-\n\n\n(3,489,326\n)\n\n\n(3,489,326\n)\n\n\n\n\nBalance as of September 30, 2024\n\n\n-\n\n$\n-\n\n\n13,363,688\n\n$\n1,336\n\n\n3,891,500\n\n$\n389\n\n$\n34,761,924\n\n$\n(31,733,646\n)\n\n$\n3,030,003\n\n\n\n\n\nAbout Inspire Veterinary Partners, Inc.\nInspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care.\nFor more information, please visit: www.inspirevet.com.\nConnect with Inspire Veterinary Partners, Inc.\nFacebook\nhttps://www.facebook.com/InspireVeterinaryPartners/\nLinkedIn\nhttps://www.linkedin.com/company/inspire-veterinary-partners/\nForward-Looking Statements\nThis press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned \"Risk Factors\" in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.\nInvestor Contact\nTraDigital IRKevin McGrath+1-646-418-7002kevin@tradigitalir.com\nGeneral Inquires\nMorgan WoodMwood@inspirevet.com\n\nSOURCE: INSPIRE VETERINARY PARTNERS, INC.\n\nView the original \npress release on accesswire.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483861449"}